NIA Small Business Programs’ Post

Attention fellow healthcare professionals! This year's theme, "Never too early, never too late", spotlights the critical role we play in early detection and intervention of Alzheimer's. 📌 Clinical Insights: > Alzheimer's leads to brain shrinkage affecting cognitive functions. > Distinguishing Alzheimer's from typical age-related memory loss is essential for correct management. > While no cure exists, timely interventions can significantly enhance patient quality of life. As we mark this day, let's commit to refining our clinical approach, enhancing patient education, and advocating for research. Join #GAPIO in leading the charge towards a world with better Alzheimer's care. #WorldAlzheimersDay #NeverTooEarlyNeverTooLate #GAPIOAdvocacy 🌍🔬📚

👩⚕️👨⚕️ Dear Doctors, Our population is rapidly ageing, leading to a surge in Dementia cases. 🧠 Join our study on "Knowledge, Attitude, and Practice in Dementia." Your participation is crucial in shaping better management strategies for an ageing population with Dementia. 🌐 https://lnkd.in/gNUFB2ii Let's work together for improved healthcare. Thank you for your valuable contribution! 🙌 Suman Kushwaha #dementia #dementiacare #dementiasupport #dementiaawareness #dementiaeducation

The Research Innovation Team at Alzheimer’s Society is exploring how they can improve access to a timely and accurate diagnosis, particularly for younger people. They are looking to develop a solution that enables clinicians and their patients to access more valuable health data in their appointments. They are keen to understand what information is most valuable for clinicians to have access to in appointments. They would value input from clinicians by completing the form below to help inform what the solution looks like. They are also keen to understand whether people living with and affected by dementia would be comfortable recording health data before appointments. They would value people affected by young onset dementia sharing their views by completing the form below to help inform what the solution looks like. Form for clinicians: https://bit.ly/47A1lV6 Form for people living with young onset dementia and family members: https://bit.ly/455W9Xu

Did you know that all of our previous #brainhealth webinars are available for on-demand viewing? Watch the recording of Patients’ Perceptions, Misconceptions, and Desires Around Dementia Prevention and Care Today to hear from Alvaro Pascual-Leone, MD, PhD and Soo Borson, MD about: - The benefits of early detection of #dementia on patient care and the implications of projected patient demand for testing and treatment for healthcare organizations - Best practices for supporting patients through intervention options - Strategies to close current cognitive care gaps

Exciting new research suggests that balance measures derived from an insole sensor can help differentiate prodromal Dementia with Lewy Bodies (MCI-LB) from other conditions. In a study with 98 participants, a machine learning-based pipeline accurately identified MCI-LB with up to 78.0% accuracy, surpassing traditional demographic and clinical measures. This breakthrough could revolutionize the timely identification of MCI-LB and lead to improved care for patients. Read the full blog post here: [Link to the blog post](https://bit.ly/3EK5kkN). #Dementia #NeurodegenerativeDisorders #HealthcareResearch

Did you miss our roundtable on dementia assessment and care? 🧠 Our esteemed panel, featuring Prof. Adrian Owen OBE, PhD, Dr. Justin Hunt from Oak Street Health, and Yukon Neurology RN Melissa Picchione, discussed the future of dementia care amidst an aging population. They emphasized the importance of early and accurate detection and how leveraging technology can significantly enhance care. Catch up on this insightful discussion and learn more about the latest advancements in dementia care. 🔗 Follow this link to view a recording of the session: https://hubs.li/Q02BnkYm0.

The Alzheimer's Association® International Conference (AAIC) in Philadelphia, Pennsylvania is just over a week away. Are you attending? Amanda Paley from AiCure will be there. Take some time and connect with her to learn how AiCure's Patient Engagement AI is tailor-made for dementia trials. You can schedule a time to meet with her at the conference here: https://lnkd.in/e2XbViCj "The AAIC is the largest international meeting dedicated to advancing dementia science and clinical practice. Each year, AAIC convenes researchers, clinicians and dementia professionals from all career stages to share breaking research discoveries and clinical practice education that will lead to improvements in diagnosis, risk reduction and treatments for Alzheimer's disease and other dementia. From basic science to dementia care, every aspect of the field’s growing knowledge of dementia is incorporated into this world-class conference." Learn more about the conference here: https://aaic.alz.org/ #AAIC24 #Dementia

Storytelling can be a powerful way to highlight the value of participating in dementia research. Gain access to videos, like Teriko's story on why she participated in a clinical study, and other tools for Alzheimer’s clinical trial recruitment via OutreachPro: https://lnkd.in/eQ9UAjhk. #NIHAging #OutreachPro #ClinicalTrials #Alzheimers #Recruitment

Public engagement plays an important role in the work of physicians and researchers. It is essential to develop contact points between health professionals and citizens outside the fast-paced environment of the hospitals. It is also vital to establish effective communication, free of the jargon of academia. In Modena, each year we dedicate a day to public engagement to promote the latest knowledge in the field of dementia. We also express our gratitude to all the individuals with lived experiences and their families, whose interest and participation make our research projects and clinical trials possible. The third edition of this initiative will be held on Saturday, February 17th, and there will be plenty of information! Silvia Cossutti will present on the clinical trials for Alzheimer’s disease and frontotemporal dementia that are currently active at our centre. Chiara Gallingani will discuss the role of neurofilaments in assessing the causes of cognitive decline. Finally, I will talk about the evidence synthesis process and share the results of a systematic review on the prognosis of mild cognitive impairment. Giovanna Zamboni Manuela Tondelli Stefano Meletti Andrea Fabbo Università degli Studi di Modena e Reggio Emilia Azienda Ospedaliera - Universitaria di Modena #Alzheimers #dementia #brainhealth #MCI #healthliteracy #clinicaltrials #scicomm 

🧠 If you’ve recently received a dementia diagnosis and you’re wondering what options are out there, you might be curious about clinical trials. Participating in #dementia research can mean gaining access to cutting-edge new treatments — while accelerating the search for a cure. Our guide covers everything you need to know before signing up for a dementia clinical trial, including risks, benefits, and what to expect. 🔗 Learn more: https://bit.ly/3Ed6k0L